Application Notes

Evaluation of TCR-pMHC affinity and its implications for T cell responsiveness (by Quality Assistance)

Simultaneous phenotype, gene expression, and TCR sequence analysis of 5-OP-RU-specific MAIT cells

Analyze the Response of SARS-CoV-2 Spike-Specific B Cells to Using Klickmer® Technology

Maximize the Potential of TCR-T Cell Therapy with Antigen-Specific Solutions and Dextramer® Technology

Advancing TCR Discovery – Dextramer® Technology for Discovery of TCRs with Greater Therapeutic Value

Monitoring Long Term T-Cell Immunity In COVID-19 using SARS-CoV-2 Dextramer® Panels

Single-Cell Evaluation Using dCODE Dextramer® Reagents and 10x Genomics Feature Barcode Protocol

Uncover antigen-specific immune cell responses and provide new insights in vaccine development

Identification of antigen-specific B cells at single-cell level for antibody discovery with dCODE® Klickmer

Dextramer CMV Kit used in Clinical Study on CMV Reactivation Risk after Allo-HCST Transplantation

Human liver CD14+CD8+ T cells enriched in cellular immune responses to hepatitis B virus and cancer

Stringent identification and enumeration of a transient TCR T cell product for in vivo activity assessment

Immunophenotype and Persistence of T Cells in Phase I Trial of TCR-T Cell Therapy Targeting MAGE-A4

Validation of MAIT Cells with TCRs Engineered to Recognize HBV infected cells using MHC Dextramer®

Screening for Cross-Reactivity and Validation of PC-CAR T Cells using MHC Dextramer®

Identifying Shared Tumor Epitopes for High Avidity Cytotoxic TILs using MHC Dextramer®

Exploring Neoantigen Cancer Vaccines and Checkpoint Inhibitors with MHC Dextramer®

Identification of Epitope Targets for Vaccination and T-cell Therapies with Klickmer®

Measurement of SARS-CoV-2 T-cell Responses in Patient Samples with MHC I Dextramer®

Capturing Primary and Secondary Anti-Yellow Fever T-Cell Responses with MHC I Dextramer®

Investigating the Effect of Therapeutic Peptide on Tumor-Infiltrating Leukocytes

CD8+ T-Cell Signature in Acute SARS-CoV-2 Infection Identifies Memory Precursors

Efficient In-situ Detection of Antigen-Specific, Autoreactive CD4+ T Cells with MHC II Dextramer®

Plasmacytoid Dendritic Cell Line-Based Vaccine Primes and Expands Antitumor T Cells in Melanoma Patients

A New TCR-Accepting T-Cell (TnT) Platform to Profile Tumor-Specific T-Cell Receptors

Assessing the HLA-Specificity of CAR-T Cells with MHC I Dextramer® Reagents

Cancer Neoepitopes for Immunotherapy: Developing Strategies for Adoptive T-Cell Therapy

CD8+ T-Cell signature in acute SARS-CoV-2 infection identifies memory precursors

Superior detection of self-reactive, antigen-specific T-cells using Klickmer® compared to tetramers

Supporting novel insights into autoimmune type 1 diabetes and adaptive immunity

Assessment of the safety and efficacy of a novel vaccine in high-grade glioma patients with Dextramer®

Evaluation of efficacy and immunity following vaccination with an RNA cancer vaccine

Support the stratification of antiviral treatment after allogeneic hematopoietic cell transplantation

Mapping of the SARS-CoV-2 epitope-specific T-cell response using dCODE Dextramer®

dCODE Dextramer® (HiT) allows multiplexing Screening of large epitope panels

Epitope-specific T-cell response in a cohort of COVID-19 recovered patients using MHC I Dextramer®

Single-cell level characterization of T cells with dCODE Dextramer® and BD Rhapsody

CAR-T cell monitoring using specific multimers: a fast and specific method allowing uniform evaluation

Developing a Platform for High-Throughput Screening of TCR Mimic Specificity using TCRm Dextramer®

Advanced Peptide Pool Negative Control Dextramer® Reagents in Antigen-Specific T Cell Detection

TCR Discovery and Detection of Antigen-Presentation on Cells using the Dextramer® Technology

Single-Cell Multi-Omics Analysis of the SARS-CoV-2 Immune Response Using U-Load dCODE Dextramer®

Identification of functional MAIT-specific TCRs using MR1 dCODE Dextramer® reagents

TCR Discovery and Detection of Antigen-Presentation on Cells using the Dextramer® Technology

Dissecting MAIT cell phenotype and TCR sequences using single-cell RNA sequencing

Extended antigen specific cellular responses by single-cell immune profiling using dCODE® technology

Production of High Quality MHC and TCR Monomers and their Applications in Immunological Research

Discovery of antigen-specific B-cell and T-cell clonotypes using a multiplexed dCODE Dextramer®-based workflow

TCR Dextramer® reagents can measure antigen presentation on peptide-pulsed cells and PBMCs

Profiling antigen-specific B cells and CD4+/CD8+ T cells after SARS-CoV-2 infection and vaccination

Profiling of the antigen-specific immune response using Dextramer® and dCODE® reagents (10x)

Antigen-Specific Solutions for T-Cell Therapy Development and Manufacturing

Monitoring of naturally acquired and vaccine induced SARS-CoV-2 Specific CD8+ T cells

Rapid Klickmer® assay for detection of SARS-CoV-2 Spike-Specific B cells upon Vaccination

Proficiency Panels: Testing and Confirming Global MHC Multimer Consistency Between Labs in 2021

Proficiency Panels: Testing and Confirming Global ELISpot Consistency Between Labs in 2021

Advancements in single-cell multiomic profiling of antigen-specific T cells with dCODE Dextramer® (RiO)

Monitoring of vaccine-induced SARS-CoV-2-specific cellular immune responses

The utility of a Dextramer® assay to detect Borrealia-specific T cells as diagnostic biomarkers of Lyme disease.

Characterization of antigen-specificity, TCR clonotype, and gene expression of single CD4+ T cells.

Discover the dCODE Dextramer® technology for T-cell epitope profiling and single cell phenotyping.

Large panels of dCODE Dextramer® to evaluate antigen-specific T-cell immunity at single-cell level.

Simultaneous single cell analysis of multiple analytes resolves T-cell populations at high resolution.

dCODE Dextramer®, a new multimer technology for T-cell epitope profiling and single cell deep phenotyping.

Multi-omics characterization of T-cell populations at single-cell level with dCODE Dextramer® and BD® AbSeq.

Monitoring of naturally acquired and vaccine-induced SARS-CoV-2 cellular immune responses.